Myhep All

Myhep All Tablet is used to treat chronic hepatitis C infection in adults and children 3 years and older. It works across all six main types of hepatitis C virus, is often combined with another medicine in difficult-to-treat cases.

When taken as directed by your doctor, Myhep All Tablet is highly effective, with most patients achieving a sustained virologic response. This meaning the virus is not detectable in the blood twelve weeks after completing treatment.

People should not take Myhep All Tablet if they are allergic to sofosbuvir, velpatasvir, or any ingredient in the medicine, are taking certain other medicines that strongly interact, such as rifampicin, or St. John’s wort.

Yes. Though rare, Myhep All Tablet can cause serious allergic reactions. Seek immediate medical help if you develop rash, swelling of the face or throat, trouble breathing, or severe dizziness.

Yes. If you have had hepatitis B in the past, Myhep All Tablet may cause the virus to become active again. Your doctor will test you for hepatitis B before starting Myhep All Tablet treatment, monitor you closely if needed.

Serious side effects of Myhep All Tablet include slow or irregular heartbeat, extreme tiredness, confusion, jaundice (yellowing skin or eyes), severe weakness, or unusual bleeding. Seek immediate medical attention if you experience any of these symptoms.

Yes, Myhep All Tablet is commonly used in patients with liver disease, including compensated cirrhosis (an early, often asymptomatic stage of cirrhosis where the liver is significantly scarred but still functioning well enough for the body to compensate for the damage). However, if you have decompensated cirrhosis, your doctor may prescribe Myhep All Tablet with other medicine, monitor you more closely.

Yes. When Myhep All Tablet is taken with another medicine called amiodarone, it can cause dangerous slowing of the heart rate. Patients on amiodarone need close monitoring, especially at the start of treatment.